Your session is about to expire
← Back to Search
Exercise Timing for Type 2 Diabetes
Study Summary
This trial will test whether Noom, a weight-loss app, helps people with type 2 diabetes better stick to their exercise and diet plan, leading to more weight loss and better health.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have type 1 diabetes and need insulin.You are allergic to perflutren, which is in the study drug Definity.My BMI is either above 46 or below 27.I am currently on medication that affects my heart rate or rhythm.I am between 30 and 70 years old.You have an unusual kidney function test result.You have health reasons that make it unsafe for you to participate in an exercise training program.You have very high levels of triglycerides (over 400 mg/dl) and cholesterol (over 260 mg/dl).You have been doing intense exercise more than twice a week in the past month.I am currently on medication to help with weight loss.I have been diagnosed with type 2 diabetes.Your body mass index is between 28 and 45.You have a history of serious health problems that could affect the study results or your safety, according to the doctor.I am currently smoking or quit less than a year ago.Your weight has changed by more than 2 kilograms in the past 3 months.Your blood pressure is very high, above 160/100 mmHg.
- Group 1: Exercise Afternoon
- Group 2: Exercise Morning
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For whom is eligibility criteria established to join this medical trial?
"This clinical study seeks 63 individuals, aged 30 to 70 years old with metabolic syndrome. To be eligible for the trial, patients must have a BMI between 28 and 45 kg/m2, not be taking any cardiovascular medications (i.e. calcium channel blockers, nitrates or alpha- or beta-blockers) and are of either gender."
Does the research protocol allow for individuals over 35 years to be part of this investigation?
"This medical trial is open to participants aged between 30 and 70."
Are there any opportunities for participants to join this clinical trial?
"The information on clinicaltrials.gov indicates that this trial has been ongoing since September 25th 2021, and was last updated on January 12th 2022, meaning it is still actively recruiting participants."
What is the current participant count for this investigation?
"Affirmative. According to the information present on clinicaltrials.gov, this medical experiment has recently opened for enrollment and is actively recruiting patients who fit its criteria. Initially posted in September of 2021 and most recently updated in January 2022, 63 individuals from 3 different locations are desired participants."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger